CoChat

Progesterone receptor membrane component-1 regulates hepcidin biosynthesis

Open access

The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.

Abstract

Iron homeostasis is tightly regulated by the membrane iron exporter ferroportin and its regulatory peptide hormone hepcidin. The hepcidin/ferroportin axis is considered a promising therapeutic target for the treatment of diseases of iron overload or deficiency. Here, we conducted a chemical screen in zebrafish to identify small molecules that decrease ferroportin protein levels. The chemical screen led to the identification of 3 steroid molecules, epitiostanol, progesterone, and mifepristone, which decrease ferroportin levels by increasing the biosynthesis of hepcidin. These hepcidin-inducing steroids (HISs) did not activate known hepcidin-inducing pathways, including the BMP and JAK/STAT3 pathways. Progesterone receptor membrane component-1 (PGRMC1) was required for HIS-dependent increases in hepcidin biosynthesis, as PGRMC1 depletion in cultured hepatoma cells and zebrafish blocked the ability of HISs to increase hepcidin mRNA levels. Neutralizing antibodies directed against PGRMC1 attenuated the ability of HISs to induce hepcidin gene expression. Inhibiting the kinases of the SRC family, which are downstream of PGRMC1, blocked the ability of HISs to increase hepcidin mRNA levels. Furthermore, HIS treatment increased hepcidin biosynthesis in mice and humans. Together, these data indicate that PGRMC1 regulates hepcidin gene expression through an evolutionarily conserved mechanism. These studies have identified drug candidates and potential therapeutic targets for the treatment of diseases of abnormal iron metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci83831

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Research works printed but not linked: 1

  1. E-mail: peterson@cvrc.mgh.harvard.edu. Or to: Erg11p/Cyp51p in Saccharomyces cerevisiae. Mol Cell Biol. 2005;25(5):1669-1679.

Cited by

Metadata

Authors
Li, X., Rhee, D. K., Malhotra, R., Mayeur, C., Hurst, L. A., Ager, E., Shelton, G., Kramer, Y., McCulloh, D., Keefe, D., Bloch, K. D., Bloch, D. B., & Peterson, R. T.
Affiliations
  • Broad Institute (US)
  • Cardiovascular Research Center (BR)
  • Harvard University (US)
  • NYU Langone Health (US)
Venue
Journal of Clinical Investigation
Published
2015-12-14
Volume
126
Issue
1
Pages
389-401
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2201070551
Cited by
112
References
68
Citations by year
2026: 7 · 2025: 7 · 2024: 3 · 2023: 23 · 2022: 9 · 2021: 15 · 2020: 9 · 2019: 13 · 2018: 5 · 2017: 10 · 2016: 10
FWCI
6.54
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Massachusetts General Hospital
  • Fondation Leducq (T32HL007208)
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (K08HL111210, T32HL007208)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082971)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
PGRMC1, ferroportin, iron homeostasis, steroid hormones, progesterone, mifepristone, Src family kinases, iron overload, iron deficiency, drug candidates
MeSH terms
Ferroportin, Androstanols, Animals, Female, Gene Expression Regulation, Humans, Membrane Proteins, Progesterone, Receptors, Progesterone, Zebrafish, Signal Transduction, Mifepristone, Bone Morphogenetic Proteins, Cation Transport Proteins, STAT3 Transcription Factor, Mice, Hep G2 Cells, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.